Ulcerative Colitis Flare Leads To Colon Cancer Diagnosis In Dad

  • 📰 TODAYshow
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 55%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Meghan Holohan is a digital health reporter for TODAY.com and covers patient-centered stories, women’s health, disability and rare diseases.

In 2009, Michael Sheridan was diagnosed with ulcerative colitis, a type of inflammatory bowel disease. Through “trial and error,” he eventually found ways to control his symptoms. Suddenly in 2019, they returned. “I started to have a flare up and it came out of the blue and hit me hard,” Sheridan, 36, of Lancaster, Ohio tells TODAY.com. “I was able to get it back under control relatively quickly within a few months.

He kept detailed records of how he felt after treatment and monitored symptoms, including neuropathy — nerve damage sometimes brought on by chemo. When the neuropathy began, he worried about how the changes would affect him in the long term and spoke to his doctors about what they could do to address it. “We ended up deciding to cut the chemo short just because I started having some neuropathy that wasn’t going away, which is kind of the first sign of being permanent damage,” Sheridan says.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 389. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Vedolizumab Shows Greater Treatment Persistence Than Tofacitinib in Ulcerative ColitisVedolizumab had greater treatment persistence than tofacitinib in a retrospective study of patients with ulcerative colitis (UC) who were previously bio-naive.
Source: Medscape - 🏆 386. / 55 Read more »